Clinical trial
Effects of N-acetyl Cysteine on Major Cardiac and Cerebral Events in Patients Undergoing Primary Percutaneous Coronary Intervention Who Have Moderate to High Risk For Contrast Induced Nephropathy
NCT01878344 is registered in ClinicalTrials.gov with Suleyman Demirel University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of N-acetyl Cysteine on Major Cardiac and Cerebral Events in Patients Undergoing Primary Percutaneous Coronary Intervention Who Have Moderate to High Risk For Contrast Induced Nephropathy
- Lead sponsor
- Suleyman Demirel University
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- January 31, 2013
- Completion date
- December 31, 2026
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute st segment elevation myocardial infarction